Literature DB >> 23083517

Can we eliminate squamous cell carcinoma of the lung from testing of EML4-ALK fusion gene?

Nobuaki Ochi, Hiromichi Yamane, Tomoko Yamagishi, Nagio Takigawa, Yasumasa Monobe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23083517     DOI: 10.1016/j.lungcan.2012.09.017

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


× No keyword cloud information.
  5 in total

1.  Detection of ALK protein expression in lung squamous cell carcinomas by immunohistochemistry.

Authors:  Jiandong Wang; Qin Shen; Qunli Shi; Bo Yu; Xuan Wang; Kai Cheng; Guangming Lu; Xiaojun Zhou
Journal:  J Exp Clin Cancer Res       Date:  2014-12-21

Review 2.  ALK in Non-Small Cell Lung Cancer (NSCLC) Pathobiology, Epidemiology, Detection from Tumor Tissue and Algorithm Diagnosis in a Daily Practice.

Authors:  Paul Hofman
Journal:  Cancers (Basel)       Date:  2017-08-12       Impact factor: 6.639

3.  Clinical features of squamous cell lung cancer with anaplastic lymphoma kinase (ALK)-rearrangement: a retrospective analysis and review.

Authors:  Junko Watanabe; Shinsaku Togo; Issei Sumiyoshi; Yukiko Namba; Kentaro Suina; Takafumi Mizuno; Kotaro Kadoya; Hiroaki Motomura; Moe Iwai; Tetsutaro Nagaoka; Shinichi Sasaki; Takuo Hayashi; Toshimasa Uekusa; Kanae Abe; Yasuo Urata; Fuminori Sakurai; Hiroyuki Mizuguchi; Shunsuke Kato; Kazuhisa Takahashi
Journal:  Oncotarget       Date:  2018-05-08

Review 4.  Detecting Resistance to Therapeutic ALK Inhibitors in Tumor Tissue and Liquid Biopsy Markers: An Update to a Clinical Routine Practice.

Authors:  Paul Hofman
Journal:  Cells       Date:  2021-01-15       Impact factor: 6.600

5.  ALK-rearranged squamous cell carcinoma of the lung.

Authors:  Qiyi Meng; Yujie Dong; Hong Tao; Liang Shi; Li Tong; Junfang Tang; Shucai Zhang; Zhe Liu
Journal:  Thorac Cancer       Date:  2021-02-09       Impact factor: 3.500

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.